Clever Leaves Holdings Inc.
CLVRDelisted May 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819615
Clever Leaves Holdings Inc. was delisted on May 6, 2024; its insiders filed their last Form 4 on Mar 12, 2024; 11 institutions reported holding it in 13F filings for Q1 2024, worth $514.5K in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Clever Leaves Holdings Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Clever Leaves Holdings Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Hague Henry R III | Chief Financial Officer | 11,951 | Mar 12, 2024 | 0 |
| Fajardo Andres | Chief Executive Officer | 21,795 | Jan 23, 2024 | 0 |
| Wilches Julian | Chief Regulatory Officer | 7,408 | Jan 23, 2024 | 0 |
| Muecke William | Director | 110,257 | Jun 30, 2023 | 0 |
| Julien Gary M | Director | 122,025 | Jun 30, 2023 | 0 |
| Demarse Elisabeth H | Director | 122,276 | Jun 27, 2023 | 0 |
| Schultze George J | Director | 115,276 | Jun 27, 2023 | 0 |
| Kastin David | General Counsel | 172,151 | Jul 6, 2022 | 0 |
| Schultze Special Purpose Acquisition Sponsor, LLC | 10% Owner | – | Feb 4, 2022 | 0 |
| Detwiler Kyle | Chief Executive Officer | 2,652,771 | Jan 18, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2024 (view filing) | Mar 8 | 4 days | Hague Henry R IIIChief Financial Officer | SSale | −170 | $3.31 | −$562.7 | −1.4%12.0K after | |
| Feb 29, 2024 (view filing) | Feb 27 | 2 days | Hague Henry R IIIChief Financial Officer | SSale | −411 | $3.95 | −$1.62K | −3.3%12.1K after | |
| Jan 23, 2024 (view filing) | Jan 19 | 4 days | Wilches JulianChief Regulatory Officer | SSale | −131 | $2.88 | −$377.28 | −1.7%7.41K after | |
| Jan 23, 2024 (view filing) | Jan 19 | 4 days | Fajardo AndresChief Executive Officer | SSale | −1.56K | $2.88 | −$4.50K | −6.7%21.8K after | |
| Dec 22, 2023 (view filing) | Dec 20 | 2 days | Wilches JulianChief Regulatory Officer | SSale | −135 | $2.04 | −$275.4 | −1.8%7.54K after | Amended |
| Dec 22, 2023 (view filing) | Dec 20 | 2 days | Fajardo AndresChief Executive Officer | SSale | −177 | $2.04 | −$361.08 | −0.8%23.4K after | Amended |
| Jul 19, 2023 (view filing)4:05 PM ET | Jul 18 | 1 day | Wilches JulianChief Regulatory Officer | SSale | −813 | $0.2152 | −$174.96 | −0.4%230.2K after | |
| Jul 19, 2023 (view filing)4:03 PM ET | Jul 18 | 1 day | Hague Henry R IIIChief Financial Officer | SSale | −1.56K | $0.2152 | −$335.71 | −0.4%375.9K after | |
| Jul 19, 2023 (view filing)4:01 PM ET | Jul 18 | 1 day | Fajardo AndresChief Executive Officer | SSale | −2.94K | $0.2152 | −$632.26 | −0.4%706.0K after | |
| Jun 30, 2023 (view filing)4:03 PM ET | Jun 29 | 1 day | Muecke WilliamDirector | SSale | −251 | $0.2058 | −$51.66 | −0.2%110.3K after | |
| Jun 30, 2023 (view filing)4:01 PM ET | Jun 29 | 1 day | Julien Gary MDirector | SSale | −251 | $0.2058 | −$51.66 | −0.2%122.0K after | |
| Mar 6, 2023 (view filing)3:36 PM ET | Mar 3 | 3 days | Hague Henry R IIIChief Financial Officer | SSale | −5.68K | $0.3682 | −$2.09K | −2.8%194.5K after | |
| Feb 27, 2023 (view filing)4:07 PM ET | Feb 24 | 3 days | Hague Henry R IIIChief Financial Officer | SSale | −9.02K | $0.4249 | −$3.83K | −4.3%200.2K after | |
| Feb 24, 2023 (view filing)6:41 PM ET | Feb 22 | 2 days | Hague Henry R IIIChief Financial Officer | SSale | −9.73K | $0.4402 | −$4.28K | −4.4%209.2K after | |
| Jan 19, 2023 (view filing)11:34 AM ET | Jan 17 | 2 days | Fajardo AndresChief Executive Officer | SSale | −57.7K | $0.4006 | −$23.1K | −9.9%525.9K after | |
| Jan 19, 2023 (view filing)11:31 AM ET | Jan 17 | 2 days | Wilches JulianChief Regulatory Officer | SSale | −4.56K | $0.4006 | −$1.83K | −8.7%48.0K after | |
| Dec 22, 2022 (view filing)1:16 PM ET | Dec 20 | 2 days | Fajardo AndresChief Executive Officer | SSale | −5.13K | $0.34 | −$1.75K | −0.9%583.6K after | |
| Dec 22, 2022 (view filing)1:06 PM ET | Dec 20 | 2 days | Wilches JulianChief Regulatory Officer | SSale | −3.83K | $0.34 | −$1.30K | −6.8%52.6K after | |
| Jul 6, 2022 (view filing) | Jul 6 | Same day | Wilches JulianChief Regulatory Officer | SSale | −288 | $1.03 | −$296.64 | −0.5%56.4K after | |
| Jul 6, 2022 (view filing) | Jul 6 | Same day | Kastin DavidGeneral Counsel | SSale | −565 | $1.03 | −$581.95 | −0.3%172.2K after | |
| Jul 6, 2022 (view filing) | Jul 6 | Same day | Hague Henry R IIIChief Financial Officer | SSale | −598 | $1.03 | −$615.94 | −0.3%218.9K after | |
| Jul 6, 2022 (view filing) | Jul 6 | Same day | Fajardo AndresChief Executive Officer | SSale | −1.17K | $1.03 | −$1.21K | −0.2%588.7K after | |
| Mar 3, 2022 (view filing) | Mar 3 | Same day | Kastin DavidGeneral Counsel | SSale | −2.36K | $1.00 | −$2.36K | −1.4%172.7K after | |
| Mar 3, 2022 (view filing) | Mar 3 | Same day | Hague Henry R IIIChief Financial Officer | SSale | −4.98K | $1.00 | −$4.98K | −2.2%219.5K after | |
| Jan 3, 2022 (view filing) | Dec 30, 2021 | 4 days | Detwiler KyleChief Executive Officer | SSale | −46.4K | $0.00 | $0 | −2.1%2.15M after | Amended |
| Jan 3, 2022 (view filing) | Dec 30, 2021 | 4 days | Kastin DavidGeneral Counsel | SSale | −1.68K | $3.20 | −$5.37K | −10.3%14.6K after | |
| Jan 3, 2022 (view filing) | Dec 30, 2021 | 4 days | Fajardo AndresPresident | SSale | −4.47K | $3.20 | −$14.3K | −6.0%69.9K after | |
| Jan 3, 2022 (view filing) | Dec 30, 2021 | 4 days | Wilches JulianChief Regulatory Officer | SSale | −3.32K | $3.20 | −$10.6K | −8.3%36.5K after |